Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1
Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1
Recruiting · NCT07598643 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1 | Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Down syndrome, Neurobehavioral Manifestations, Neurologic Manifestations, chromosomal disorder, hereditary disease, intellectual disability, nervous system disorder | Recruiting | Phase 2 | 2026-09-03 | NCT07598643 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Anschutz Acceleration Initiative | 1 |
| GLOBAL Down Syndrome Foundation | 3 |
| University of Colorado, Denver | 475 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CU Anschutz, Children's Hospital Colorado | Aurora | United States | 1 |